These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 4359995
1. Clinical evaluation of indoramin, a new antihypertensive agent. Lewis PJ, George CF, Dollery CT. Eur J Clin Pharmacol; 1973 Dec; 6(4):211-6. PubMed ID: 4359995 [No Abstract] [Full Text] [Related]
2. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension. Kramer R, Rosendorff C, Bloom D. S Afr Med J; 1974 Aug 03; 48(37):1569-72. PubMed ID: 4851044 [No Abstract] [Full Text] [Related]
3. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent. Royds RB. Br J Pharmacol; 1972 Feb 03; 44(2):379P-380P. PubMed ID: 4668635 [No Abstract] [Full Text] [Related]
4. Studies relating to the antihypertensive and antidysrhythmic action of indoramin. Baum T, Shropshire AT, Eckfeld DK, Metz N, Dinish JL, Peters JR, Butz F, Gluckman MI. Arch Int Pharmacodyn Ther; 1973 Aug 03; 204(2):390-406. PubMed ID: 4356047 [No Abstract] [Full Text] [Related]
5. Double blind controlled trial of indoramin in the treatment of essential hypertension. Dollery DT, George DG, Lewis PJ. Br J Pharmacol; 1972 Nov 03; 46(3):542P-543P. PubMed ID: 4571183 [No Abstract] [Full Text] [Related]
6. Clinical evaluation of SE 1520 in the treatment of hypertension. Seedat YK, Reddy J. Curr Ther Res Clin Exp; 1974 Apr 03; 16(4):275-80. PubMed ID: 4208341 [No Abstract] [Full Text] [Related]
7. The treatment of arterial hypertension with a new alpha-blocker, indoramin. Carballo R, Conde L, Lapelle M, Suarez J. Curr Med Res Opin; 1974 Apr 03; 2(8):437-43. PubMed ID: 4155664 [No Abstract] [Full Text] [Related]
9. [Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report]. Torres Zamora M, García Monterd G, Chávez Domínguez R, Chávez Lara B, Serrano PA. Arch Inst Cardiol Mex; 1974 Apr 03; 44(2):267-74. PubMed ID: 4599277 [No Abstract] [Full Text] [Related]
10. The effect of parenteral indoramin on peripheral blood flow in patients with Raynaud's disease or atherosclerosis associated with intermittent claudication. Fares CM, Milliken JC. Curr Med Res Opin; 1974 Apr 03; 2(2):57-62. PubMed ID: 4151332 [No Abstract] [Full Text] [Related]
14. A double-blind study in hypertensive patients of an original new compound, indapamide. Witchitz S, Kamoun A, Chiche P. Curr Med Res Opin; 1975 Sep 03; 3(1):1-8. PubMed ID: 1090415 [Abstract] [Full Text] [Related]
15. Human pharmacology of indoramin. Coltart DJ, Lockhart JD, Royds RB, Turner P. Br J Pharmacol; 1971 Oct 03; 43(2):467P-468P. PubMed ID: 4400576 [No Abstract] [Full Text] [Related]
16. Cardiovascular and metabolic profile during intervention with urapidil in humans. Gerber A, Weidmann P, Marone C, Uehlinger D, Riesen W. Hypertension; 1985 Oct 03; 7(6 Pt 1):963-71. PubMed ID: 3908316 [Abstract] [Full Text] [Related]
17. Clinical trial with guanabenz, a new antihypertensive agent. Nash DT. J Clin Pharmacol; 1973 Oct 03; 13(10):416-21. PubMed ID: 4583572 [No Abstract] [Full Text] [Related]
18. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients. Sung PK, Samet P, Yeh BK. Curr Ther Res Clin Exp; 1971 May 03; 13(5):280-5. PubMed ID: 4998390 [No Abstract] [Full Text] [Related]
19. [Indoramin, a drug with prevalent antihypertensive activity: experimental study]. Marmo E, Rossi F, Caputi AP, Lampa E, Petrarca R, Ottavo R. Clin Ter; 1979 Feb 15; 88(3):233-62. PubMed ID: 445975 [No Abstract] [Full Text] [Related]
20. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension. Yajnik BH, Shah JS. J Assoc Physicians India; 1985 May 15; 33(5):339-43. PubMed ID: 3900029 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]